Alnylam Pharmaceuticals
ALNY
#618
Rank
A$50.88 B
Marketcap
$393.19
Share price
3.69%
Change (1 day)
78.47%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company